$1,980.00 – $3,080.00
We use our efficient integration-free, small molecule-based method to differentiate high-quality natural killer (NK) cells from human iPSCs at passage 0 (P0). The differentiated NK cells recapitulate the phenotype and functional parameters of primary and in vivo NK cells.
We provide NK cells differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African American male donor. These cryopreserved, high-purity (>80%) cells express high levels of NK biomarkers CD56 and CD45.
These iPSC-differentiated NK cells can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived NK cells for drug screening applications. These NK cells can also be used as effector cells in cytotoxicity assays.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
Fill out the contact form below and a team member will be in touch within one business day.
